• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含肟基新型双吲哚衍生物的合成与药理评价:新型促凋亡剂的鉴定

Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: identification of novel proapoptotic agents.

作者信息

Qu Hong-En, Huang Ri-Zhen, Yao Gui-Yang, Li Jiu-Ling, Ye Man-Yi, Wang Heng-Shan, Liu Liangxian

机构信息

State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Pharmaceutical Sciences of Guangxi Normal University, Guilin 541004, PR China.

Department of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China.

出版信息

Eur J Med Chem. 2015 May 5;95:400-15. doi: 10.1016/j.ejmech.2015.03.058. Epub 2015 Mar 27.

DOI:10.1016/j.ejmech.2015.03.058
PMID:25841196
Abstract

In an effort to develop potent anti-cancer chemopreventive agents, a novel series of bisindole derivatives bearing oxime moiety were synthesized. Structures of all compounds were characterized by NMR and HRMS. Anti-proliferative activities for all of these compounds were investigated by the method of MTT assay on 7 human cancer lines and the normal cell lines (HUVEC). Most of them showed a noteworthy anti-cancer activity in vitro, the half maximal inhibitory concentration (IC50) value is 4.31 μM of 4e against T24. The results from Hoechst 33258 and acridine orange/propidium iodide staining as well as annexinV-FITC assays provided evidence for an apoptotic cell death. The further mechanisms of compound 4e-induced apoptosis in T24 cells demonstrated that compound 4e induced the productions of ROS, and altered anti- and pro-apoptotic proteins, leading to mitochondrial dysfunction and activations of caspase-9 and caspase-3 for causing cell apoptosis. Moreover, the cell cycle analysis and western-blot analysis indicated that compound 4e effectively arrested T24 cells in G1 stage and possibly has an effect on cell cycle regulatory proteins particularly cyclin D1.

摘要

为了开发有效的抗癌化学预防剂,合成了一系列新型的带有肟部分的双吲哚衍生物。所有化合物的结构均通过核磁共振(NMR)和高分辨质谱(HRMS)进行了表征。采用MTT法对7种人类癌细胞系和正常细胞系(人脐静脉内皮细胞,HUVEC)研究了所有这些化合物的抗增殖活性。它们中的大多数在体外显示出显著的抗癌活性,化合物4e对T24细胞的半数最大抑制浓度(IC50)值为4.31 μM。Hoechst 33258和吖啶橙/碘化丙啶染色以及膜联蛋白V-异硫氰酸荧光素(annexinV-FITC)检测结果为凋亡性细胞死亡提供了证据。化合物4e诱导T24细胞凋亡的进一步机制表明,化合物4e诱导了活性氧(ROS)的产生,并改变了抗凋亡和促凋亡蛋白,导致线粒体功能障碍以及半胱天冬酶-9(caspase-9)和半胱天冬酶-3(caspase-3)的激活,从而引起细胞凋亡。此外,细胞周期分析和蛋白质免疫印迹分析表明,化合物4e有效地将T24细胞阻滞在G1期,并且可能对细胞周期调节蛋白尤其是细胞周期蛋白D1有影响。

相似文献

1
Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: identification of novel proapoptotic agents.含肟基新型双吲哚衍生物的合成与药理评价:新型促凋亡剂的鉴定
Eur J Med Chem. 2015 May 5;95:400-15. doi: 10.1016/j.ejmech.2015.03.058. Epub 2015 Mar 27.
2
Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.新型熊果酸衍生物作为潜在抗癌剂的设计、合成及体外评价
Eur J Med Chem. 2015 May 5;95:435-52. doi: 10.1016/j.ejmech.2015.03.051. Epub 2015 Mar 23.
3
Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.新型噻唑取代双吡唑啉肟衍生物的设计、合成及通过选择性诱导癌细胞凋亡和 ROS 产生的抗肿瘤活性的生物评价。
Med Chem. 2019;15(7):743-754. doi: 10.2174/1573406414666180827112724.
4
Synthesis and antitumor activities of novel α-aminophosphonate derivatives containing an alizarin moiety.含茜素部分的新型 α-氨基膦酸酯衍生物的合成及抗肿瘤活性。
Eur J Med Chem. 2014 Aug 18;83:116-28. doi: 10.1016/j.ejmech.2014.02.067. Epub 2014 Jun 12.
5
Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.新型苯胺衍生的积雪草苷酸衍生物作为潜在抗癌剂的合成及生物学评价
Eur J Med Chem. 2014 Oct 30;86:175-88. doi: 10.1016/j.ejmech.2014.08.003. Epub 2014 Aug 12.
6
Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.设计、合成并评价含二肽片段的新型去氢枞酸衍生物作为潜在的抗癌药物。
Eur J Med Chem. 2015 Jan 7;89:370-85. doi: 10.1016/j.ejmech.2014.10.060. Epub 2014 Oct 22.
7
Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.新型黄嘌呤衍生物的合成及生物评价作为潜在的凋亡抗肿瘤剂。
Eur J Med Chem. 2019 Aug 15;176:117-128. doi: 10.1016/j.ejmech.2019.05.015. Epub 2019 May 11.
8
New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.新型(E)-1-烷基-1H-苯并[d]咪唑-2-基亚甲基)吲哚啉-2-酮:合成、体外细胞毒性评估及凋亡诱导研究
Eur J Med Chem. 2016 Oct 21;122:584-600. doi: 10.1016/j.ejmech.2016.07.019. Epub 2016 Jul 11.
9
Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.柚皮素肟和肟醚衍生物的合成及体外抗肿瘤活性。
Int J Mol Sci. 2019 May 2;20(9):2184. doi: 10.3390/ijms20092184.
10
Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.二有机锡(IV)与4-硝基-N-邻苯二甲酰甘氨酸的配合物:合成、表征、抗肿瘤活性及DNA结合研究
Biomed Pharmacother. 2015 Apr;71:119-27. doi: 10.1016/j.biopha.2015.02.027. Epub 2015 Mar 4.

引用本文的文献

1
New imidazolidindionedioximes and their Pt(II) complexes: synthesis and investigation of their antitumoral activities on breast cancer cells.新型咪唑烷二酮二肟及其铂(II)配合物:其对乳腺癌细胞的抗肿瘤活性的合成与研究
Turk J Chem. 2024 Jan 22;48(4):582-596. doi: 10.55730/1300-0527.3681. eCollection 2024.
2
The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds.肟和肟醚部分在改善结构多样支架的物理化学和抗癌性能方面的基本作用。
Int J Mol Sci. 2023 Nov 28;24(23):16854. doi: 10.3390/ijms242316854.
3
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential.
肟类化合物:具有抗癌和抗炎潜力的新型治疗药物。
Biomolecules. 2021 May 22;11(6):777. doi: 10.3390/biom11060777.